Interference of D-dimer levels from heterophilic antibody in COVID-19: A serious concern in treatment and follow-up of patients
Corresponding Author
Demircan Ozbalci
Department of Hematology, Suleyman Demirel University School of Medicine, Isparta, Turkey
Correspondence
Demircan Ozbalci, Department of Hematology, Suleyman Demirel University School of Medicine, Dogu Yerleskesi Cunur-Isparta, Isparta, Turkey.
Email: [email protected]
Search for more papers by this authorDuygu Kumbul Doguc
Department of Biochemistry, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorGulruhsar Yilmaz
Department of Infectious Disease and Clinical Microbiology, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorOnder Ozturk
Department of Chest Diseases, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorFevziye Burcu Sirin
Department of Biochemistry, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorFusun Zeynep Akcam
Department of Infectious Disease and Clinical Microbiology, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorCorresponding Author
Demircan Ozbalci
Department of Hematology, Suleyman Demirel University School of Medicine, Isparta, Turkey
Correspondence
Demircan Ozbalci, Department of Hematology, Suleyman Demirel University School of Medicine, Dogu Yerleskesi Cunur-Isparta, Isparta, Turkey.
Email: [email protected]
Search for more papers by this authorDuygu Kumbul Doguc
Department of Biochemistry, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorGulruhsar Yilmaz
Department of Infectious Disease and Clinical Microbiology, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorOnder Ozturk
Department of Chest Diseases, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorFevziye Burcu Sirin
Department of Biochemistry, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this authorFusun Zeynep Akcam
Department of Infectious Disease and Clinical Microbiology, Suleyman Demirel University School of Medicine, Isparta, Turkey
Search for more papers by this author
CONFLICT OF INTEREST
Demircan Ozbalci, Duygu Kumbul Doguc, Gulruhsar Yilmaz, Onder Ozturk, Fevziye Burcu Sirin and Fusun Zeynep Akcam declare no conflict of interest and no financial support from any pharmaceutical companies.
REFERENCES
- 1Song JC, Wang G, Zhang W, Zhang Y, Li WQ, Zhou Z. People’s liberation army professional committee of critical care medicine, Chinese society on thrombosis and haemostasis. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res. 2020; 7(1): 19. https://doi.org/10.1186/s40779-020-00247-7. PMID: 32307014; PMCID: PMC7167301
- 2Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020; 6: 1324-1329. https://doi.org/10.1111/jth.14859. PMID: 32306492; PMCID: PMC7264730
- 3Lippi G, Ippolito L, Tondelli MT, Favaloro EJ. Interference from heterophilic antibodies in D-dimer assessment. A case report. Blood Coagul Fibrinolysis. 2014; 25(3): 277-279. https://doi.org/10.1097/MBC.0000000000000017. PMID: 24253242
- 4Zhang XY, Zhang XX, Xu JL, et al. Identification of and solution for false D-dimer results. J Clin Lab Anal. 2020; 34(6):e23216. https://doi.org/10.1002/jcla.23216. PMID: 31967356; PMCID: PMC7307351
- 5Morton A. When lab tests lie … heterophile antibodies. Aust Fam Physician. 2014; 43: 391-393. [PMID: 24897990].
- 6Datta P. Immunoassay design and mechanisms of interferences. In A Dasgupta, J Sepulveda eds. Accurate Results in the Clinical Laboratory. A Guide to Error Detection and Correction. Oxford UK: Elsevier Press; 2013: 63-73.
10.1016/B978-0-12-415783-5.00006-2 Google Scholar
- 7Barry RG. Hemosil_D-Dimer_Monograph. [Researchgate website]. 2014. January 2014. https://www.researchgate.net/publication/324065441_HemosIL_d-Dimer_Monograph. Accessed May 31, 2021
- 8Sun HX, Ge H, Xu ZQ, Sheng HM. Clinical laboratory investigation of a patient with an extremely high D-dimer level: a case report. World J Clin Cases. 2020; 8(16): 3560-3566. https://doi.org/10.12998/wjcc.v8.i16.3560. PMID: 32913864; PMCID: PMC7457100
- 9Goldman JD, Wang K, Roltgen K, et al. Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report. medRxiv. 2020; 76: 1815-1826. https://doi.org/10.1101/2020.09.22.20192443. PMID: 32995830; PMCID: PMC7523175
10.1101/2020.09.22.20192443 Google Scholar
- 10Haukenes G, Viggen B, Boye B, Kalvenes MB, Flø R, Kalland KH. Viral antibodies in infectious mononucleosis. FEMS Immunol Med Microbiol. 1994; 8(3): 219-224. https://doi.org/10.1111/j.1574-695X.1994.tb00446.x. PMID: 8004058
- 11Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol. 2020; 76(16): 1815-1826. https://doi.org/10.1016/j.jacc.2020.08.041. PMID: 32860872; PMCID: PMC7449655
- 12Daughety MM, Morgan A, Frost E, et al. COVID-19 associated coagulopathy: thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy. Thromb Res. 2020; 196: 483-485. https://doi.org/10.1016/j.thromres.2020.10.004. PMID: 33091700; PMCID: PMC7557260
Citing Literature
